Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Medicinova Inc (MNOV)  
$1.38 0.09 (6.98%) as of 4:30 Thu 5/2


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 44,930,000
Market Cap: 62.00(M)
Last Volume: 19,794 Avg Vol: 317,431
52 Week Range: $1.28 - $2.6
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MediciNova is a biopharmaceutical company. Co. is focusing its development activities on MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction and prevention of acute respiratory distress syndrome, and MN-001 (tipelukast) for fibrotic diseases such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis. Co.'s pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 12,646
Total Sell Value $0 $0 $0 $28,031
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 4
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 89
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nagao Hideki Director   –       •      –    2022-11-28 4 S $2.25 $15,197 D/D (6,754) 0 16%     
   Nagao Hideki Director   –       •      –    2022-11-22 4 S $2.13 $464 D/D (218) 6,754 1%     
   Nagao Hideki Director   –       •      –    2022-11-21 4 S $2.18 $11,696 D/D (5,365) 6,972 1%     
   Nagao Hideki Director   –       •      –    2022-11-17 4 S $2.18 $674 D/D (309) 12,337 1%     
   Matsuda Kazuko Chief Medical Officer   •       •      –    2021-08-23 4 OE $2.30 $138,000 D/D 60,000 322,996     -
   Iwaki Yuichi President and CEO   •       •      –    2021-07-09 4 OE $2.54 $100,541 D/D 39,583 966,933     -
   Matsuda Kazuko Chief Medical Officer   •       •      –    2021-06-24 4 OE $2.46 $256,622 D/D 102,804 262,996     -
   Obrien Geoffrey Vice President   •       –      –    2021-05-19 4 OE $2.46 $109,122 D/D 43,318 48,318     -
   Nagao Hideki Director   –       •      –    2021-03-11 4 S $7.40 $17,420 D/D (2,354) 12,646 43%     
   Iwaki Yuichi President and CEO   •       •      –    2021-02-25 4 OE $2.46 $212,175 D/D 86,250 927,350     -
   3d Opportunity Master Fund 10% Owner   –       –       •   2021-01-11 3 IO $0.00 $0 I/I 0 5,502,047 -25%     
   Nagao Hideki Director   –       •      –    2020-09-15 4 S $5.78 $5,780 D/D (1,000) 15,000 -3%     
   Nagao Hideki Director   –       •      –    2020-08-06 4 OE $2.58 $38,700 D/D 15,000 16,000     -
   Matsuda Kazuko Chief Medical Officer   •       •      –    2020-06-12 4 OE $5.13 $102,600 D/D 20,000 160,192     -
   Matsuda Kazuko Chief Medical Officer   •       •      –    2020-04-08 4 OE $2.54 $72,253 D/D 28,446 140,192     -
   Iwaki Yuichi President and CEO   •       •      –    2020-04-08 4 OE $2.54 $153,459 D/D 60,417 841,100     -
   Matsuda Kazuko Chief Medical Officer   •       •      –    2020-03-13 4/A B $3.62 $7,240 D/D 2,000 111,746 2.81     -
   Matsuda Kazuko Chief Medical Officer   •       •      –    2020-03-13 4 B $3.62 $7,240 D/D 2,000 111,476 2.81 43%     
   Iwaki Yuichi President and CEO   •       •      –    2020-03-12 4 B $3.10 $62,000 D/D 20,000 780,683 2.81 85%     
   Matsuda Kazuko Chief Medical Officer   •       –      –    2019-06-12 4 OE $4.80 $177,600 D/D 37,000 109,457     -
   Nagao Hideki Director   –       •      –    2019-05-13 4 OE $2.77 $2,770 D/D 1,000 1,000     -
   Okajima Masatsune VP and Head of Japanese Office   •       –      –    2019-02-28 4 OE $2.46 $3,718,763 D/D 886,950 1,040,530     -
   Okajima Masatsune VP and Head of Japanese Office   •       –      –    2019-01-09 4 OE $2.20 $90,750 D/D 41,250 153,580     -
   Iwaki Yuichi President and CEO   •       •      –    2019-01-03 4 OE $2.20 $40,858 D/D 18,572 759,392     -
   Iwaki Yuichi President and CEO   •       •      –    2018-03-05 4 OE $2.20 $110,007 D/D 50,003 740,594     -
  89 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us